University of Kansas Specialized Chemistry Center
University of Kansas Specialized Chemistry Center
批准号:
8336964
负责人:
Jeffrey Aube
金额:
$300.0万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2014-05-31
关键词:
AddressBiologicalBiomedical ResearchChemicalsChemistryCollectionDetectionDevelopmentEquipmentFundingGoalsGrantHandHigh Pressure Liquid ChromatographyHybridsInvestmentsKansasLaboratoriesLeadLibrariesMarshalMethodologyMolecular ProbesPharmaceutical ChemistryProductionProteinsRecording of previous eventsResearch InfrastructureResearch Project GrantsResourcesServicesStructureSystemTechniquesUnited States National Institutes of HealthUniversitiesWorkYeastsbasecheminformaticsexperiencemeetingsprogramssmall moleculesuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The University of Kansas (KU) has a history of success in synthetic medicinal chemistry that continues to the present day. NIH investments in these activities have included a Chemical Methodologies and Library Development (CMLD) center and a Pilot Scale Library grant. With strong institutional support including a new building dedicated to probe discovery, we propose to marshal these resources in the service of the MLPCN as a Specialized Chemistry Center (SCC). The goals of the KU SCC will be to synthesize 10-15 collections of probe candidates per year, with each set containing between 100-300 discrete compounds in 20 mg quantities and >90% chemical purity as determined by HPLC (UV or ESL detection). In the past 15 months, we submitted over 1600 compounds that met these requirements to the MLSCN, comprising about a dozen different chemotypes. Thus, we are already functioning at the level comparable to that required for the SCC initiative and have developed a realistic plan for quickly undertaking the challenge of optimizing hits obtained from the MLPCN partnership. Strengths of the proposed program include (1) the demonstrated capability of producing small molecules in the quantities and purities demanded by MLPCN; (2) practical know-how of how to get compounds efficiently into the hands of biological collaborators, (3) demonstrated expertise in working with biological collaborators and optimizing compound potency and selectivity of a lead compound (and an outstanding set of consultants who will provide guidance on a monthly basis), (4) practical experience with parallel synthesis techniques and outstanding infrastructure for library production, (5) assignment to a brand-new laboratory containing 11 hoods in a new building extension that is dedicated to collaborative biomedical discovery (labs to be completed in 4/08), (6) strong cheminformatics expertise, (7) an experienced PI and an existing administrative structure that will facilitate the coordination of the project activities, (8) matching funds to provide essential major equipment and set up necessary laboratories for the SCC, and (9) a demonstrated commitment to the MLSCN.
A Center-based research project is proposed to address the question of intracellular target identification for small molecule probes, an acknowledged roadblock in biomedical research. The goals of this project will be to (1) develop methodology for visualizing and identifying intracellular protein targets using fluorescent molecular probes and (2) develop yeast three-hybrid (Y3H) systems as tools for the identification of protein targets of small molecules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small Molecule Therapeutic Discovery for Angelman Syndrome
-
批准号:10636253
-
项目类别:
-
资助金额:$57.55万
-
财政年份:2023
-
负责人:Jeffrey Aube
-
依托单位:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
-
批准号:10450109
-
项目类别:
-
资助金额:$77.99万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
UNC Chemical Biology Interface Training Program
-
批准号:10646465
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
-
批准号:10653027
-
项目类别:
-
资助金额:$77.84万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
-
批准号:10298705
-
项目类别:
-
资助金额:$80.77万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
UNC Chemical Biology Interface Training Program
-
批准号:10089153
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
UNC Chemical Biology Interface Training Program
-
批准号:10415825
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2021
-
负责人:Jeffrey Aube
-
依托单位:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
-
批准号:9229013
-
项目类别:
-
资助金额:$68.4万
-
财政年份:2016
-
负责人:Jeffrey Aube
-
依托单位:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
-
批准号:9889913
-
项目类别:
-
资助金额:$63.8万
-
财政年份:2016
-
负责人:Jeffrey Aube
-
依托单位:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
-
批准号:9113893
-
项目类别:
-
资助金额:$72.1万
-
财政年份:2016
-
负责人:Jeffrey Aube
-
依托单位:
Molecular cancer therapy targeting HuR-ARE interaction
-
批准号:9297260
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2015
-
负责人:Jeffrey Aube
-
依托单位:
Molecular cancer therapy targeting HuR-ARE interaction
-
批准号:8964473
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2015
-
负责人:Jeffrey Aube
-
依托单位:
Molecular cancer therapy targeting HuR-ARE interaction
-
批准号:9069752
-
项目类别:
-
资助金额:$43.2万
-
财政年份:2015
-
负责人:Jeffrey Aube
-
依托单位:
Chemistry Core
-
批准号:10057814
-
项目类别:
-
资助金额:$76.63万
-
财政年份:2014
-
负责人:Jeffrey Aube
-
依托单位:
Small molecules modulating RNA-binding protein Msi1
-
批准号:8696948
-
项目类别:
-
资助金额:$43.25万
-
财政年份:2014
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:8636038
-
项目类别:
-
资助金额:$27.8万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:8822310
-
项目类别:
-
资助金额:$26.44万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:9326803
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:8499381
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
Structure and Function of Cytochrome P450 17A1
-
批准号:8913319
-
项目类别:
-
资助金额:$6.17万
-
财政年份:2012
-
负责人:Jeffrey Aube
-
依托单位:
海外基金